Nizhoni Health Systems LLC – Trademark Portfolio
Entity Type: 16
Nizhoni Health Systems LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 7 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include INNOVIVE HEALTH and NIZHONI HEALTH SYSTEMS. The owner is based in Somerville, MA.
4th Floor
5 Middlesex Avenue
Somerville, MA 02145
Showing of trademarks Trademarks
Trademark Classifications
Nizhoni Health Systems LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Nizhoni Health Systems LLC have?
Nizhoni Health Systems LLC has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 2 cancelled.
What trademark classes does Nizhoni Health Systems LLC file in?
Nizhoni Health Systems LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 45 (Legal & Security Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Nizhoni Health Systems LLC's most well-known trademarks?
Nizhoni Health Systems LLC's registered trademark portfolio includes well-known marks such as INNOVIVE HEALTH and NIZHONI HEALTH SYSTEMS. These are among 4 currently registered trademarks in the portfolio.
What is Nizhoni Health Systems LLC's trademark registration success rate?
Nizhoni Health Systems LLC has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.